ReleaseWire Connect

Dengue-Pipeline Insights, 2016 report provides in depth insights on the pipeline drugs and their development activities around the Dengue. The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Dengue. Publisher's Report also assesses the Dengue therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Cutaneous Lupus Erythematosus-Pipeline Insights, 2016 report provides in depth insights on the pipeline drugs and their development activities around the Cutaneous Lupus Erythematosus. The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Cutaneous Lupus Erythematosus. Publisher's Report also assesses the Cutaneous Lupus Erythematosus therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Corneal Graft Rejection-Pipeline Insights, 2016 report provides in depth insights on the pipeline drugs and their development activities around the Corneal Graft Rejection. The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Corneal Graft Rejection. Publisher's Report also assesses the Corneal Graft Rejection therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Condyloma-Pipeline Insights, 2016 report provides in depth insights on the pipeline drugs and their development activities around the Condyloma. The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Condyloma. Publisher's Report also assesses the Condyloma therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

In 2014, the output and sales of automotive industry in China were around 23.72 units and 23.49 units respectively, grew by XX% and XX%. In this report, Publisher will disclose the performance and competitiveness of the top 5 automobile Clutch Master Cylinder producers in automotive industry. Market potentials and commercial opportunities for the industry will be discussed as well. Recommendations will be given at the end of the report to describe the prospect and provide suggestions for strategy making.

In 2014, the output and sales of automotive industry in China were around 23.72 units and 23.49 units respectively, grew by XX% and XX%. In this report, Publisher will disclose the performance and competitiveness of the top 5 automobile Automatic Transmission Assembly producers in automotive industry. Market potentials and commercial opportunities for the industry will be discussed as well. Recommendations will be given at the end of the report to describe the prospect and provide suggestions for strategy making.

Chronic Heart Failure-Pipeline Insights, 2016 report provides in depth insights on the pipeline drugs and their development activities around the Chronic Heart Failure. The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Chronic Heart Failure. Publisher's Report also assesses the Chronic Heart Failure therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Chronic Asthma-Pipeline Insights, 2016 report provides in depth insights on the pipeline drugs and their development activities around the Chronic Asthma. The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Chronic Asthma. Publisher's Report also assesses the Chronic Asthma therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Chicken Pox-Pipeline Insights, 2016 report provides in depth insights on the pipeline drugs and their development activities around the Chicken Pox. The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Chicken Pox. Publisher's Report also assesses the Chicken Pox therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Chemotherapy Induced Anemia-Pipeline Insights, 2016 report provides in depth insights on the pipeline drugs and their development activities around the Chemotherapy Induced Anemia. The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Chemotherapy Induced Anemia. Publisher's Report also assesses the Chemotherapy Induced Anemia therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.